PRGO News and Press, Perrigo Company plc From 11/08/22

Perrigo Reports Third Quarter Fiscal Year 2022 Financial Results From Continuing Operations PR Newswire DUBLIN , Nov. 8, 2022 /PRNewswire/ -- Highlights: Perrigo achieved third quarter net sales of $1.1 billion , an inc...

Perrigo ( NYSE: PRGO ) said Tuesday it will invest $170M to expand its U.S. baby formula manufacturing, which will include the purchase of Nestlé's ( OTCPK:NSRGY ) Gateway plant and investment to scale up production capacity at the facility. Per...

Perrigo Announces Strategic Investment to Expand and Strengthen U.S. Manufacturing of Infant Formula Canada NewsWire Company Purchases Nestlé's Gateway Infant Formula Plant in Eau Claire, Wisconsin , along with U.S. and Canadian rights to the Good Start ...

Ireland-based pharma Perrigo ( NYSE: PRGO ) slipped in the morning hours Wednesday after announcing that the FDA has postponed a meeting for its advisory committee that was scheduled to discuss the marketing application for oral contraceptive Opill for Over-The-Counter (OTC) use...

Perrigo Receives Notification of Postponement for Joint FDA Advisory Committee to Review Opill® Daily Oral Contraceptive for Over-The-Counter (OTC) Use PR Newswire DUBLIN , Oct. 26, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO) ("Perrigo" or ...

Perrigo to Release Third Quarter 2022 Financial Results on November 8, 2022 PR Newswire DUBLIN , Oct. 25, 2022 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it will release it...

Summary Uncertain outlook prompts stock market investors to seek protection. US-listed stocks of loyal dividend payers with robust activity also serve as effective hedging tools against market headwinds. Among US-listed dividend payers, Perrigo Company plc stands out in better...

Learn how to generate a second income stream with the same cash in the same contract month when covered call writing, states Alan Ellman of The Blue Collar Investor. For further details see: Mid-Contract Unwind Exit Strategy for Covered Call Writing

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further detai...

Argus Research upgraded OTC product maker Perrigo Company plc ( NYSE: PRGO ) to Buy from Hold, noting that the momentum PRGO saw in Q2, thanks to its focus on consumer self-care, could continue despite macro headwinds. While the company has faced the impact of industry-wide ...